Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Aug;36(8):1794–1796. doi: 10.1128/aac.36.8.1794

Susceptibilities of ampicillin-resistant strains of Salmonella other than S. typhi to 10 antimicrobial agents.

J I Alós 1, J L Gómez-Garcés 1, R Cogollos 1, E Amor 1, A Pérez-Rivilla 1
PMCID: PMC192052  PMID: 1416869

Abstract

Ampicillin-resistant strains of Salmonella other than S. typhi constitute a health problem. We tested the antimicrobial susceptibilities to 10 antibiotics of 57 of these strains isolated in a 30-month period. The rates of resistance were as follows: chloramphenicol, 40.3%; tetracycline, 33.3%; gentamicin, 5.3%; co-trimoxazole, 5.3%; nalidixic acid, 1.8%; and amoxicillin-clavulanic acid, cefotaxime, ceftriaxone, aztreonam, and ciprofloxacin, 0%. In our experience, there are alternative antibiotics with excellent in vitro activities.

Full text

PDF
1794

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguiar J. M., Chacon J., Canton R., Baquero F. The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother. 1992 Mar;29(3):349–350. doi: 10.1093/jac/29.3.349. [DOI] [PubMed] [Google Scholar]
  2. Alós J. I., González-Palacios R., Sánchez-Moreno M. P., Calderón P. Alta frecuencia de elevada resistencia a ampicilina en Salmonella spp no typhi. Med Clin (Barc) 1990 Jun 30;95(5):175–177. [PubMed] [Google Scholar]
  3. Archambaud M., Gerbaud G., Labau E., Marty N., Courvalin P. Possible in-vivo transfer of beta-lactamase TEM-3 from Klebsiella pneumoniae to Salmonella kedougou. J Antimicrob Chemother. 1991 Apr;27(4):427–436. doi: 10.1093/jac/27.4.427. [DOI] [PubMed] [Google Scholar]
  4. Aserkoff B., Bennett J. V. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med. 1969 Sep 18;281(12):636–640. doi: 10.1056/NEJM196909182811202. [DOI] [PubMed] [Google Scholar]
  5. Ben Redjeb S., Ben Yaghlane H., Boujnah A., Philippon A., Labia R. Synergy between clavulanic acid and newer beta-lactams on nine clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella typhimurium resistant to third-generation cephalosporins. J Antimicrob Chemother. 1988 Feb;21(2):263–266. doi: 10.1093/jac/21.2.263. [DOI] [PubMed] [Google Scholar]
  6. Chalker R. B., Blaser M. J. A review of human salmonellosis: III. Magnitude of Salmonella infection in the United States. Rev Infect Dis. 1988 Jan-Feb;10(1):111–124. doi: 10.1093/clinids/10.1.111. [DOI] [PubMed] [Google Scholar]
  7. Cherubin C. E. Antibiotic resistance of Salmonella in Europe and the United States. Rev Infect Dis. 1981 Nov-Dec;3(6):1105–1126. doi: 10.1093/clinids/3.6.1105. [DOI] [PubMed] [Google Scholar]
  8. Cherubin C. E., Eng R. H. Quinolones for the treatment of infections due to Salmonella. Rev Infect Dis. 1991 Mar-Apr;13(2):343–344. doi: 10.1093/clinids/13.2.343. [DOI] [PubMed] [Google Scholar]
  9. Cohen J. I., Bartlett J. A., Corey G. R. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987 Sep;66(5):349–388. doi: 10.1097/00005792-198709000-00003. [DOI] [PubMed] [Google Scholar]
  10. Echeita M. A., Usera M. A. Prevalence of Salmonella serotypes isolated in Spain from human and non human sources (1983-1987). Microbiologia. 1989 Sep;5(2):95–103. [PubMed] [Google Scholar]
  11. Farhoudi-Moghaddam A. A., Katouli M., Jafari A., Bahavar M. A., Parsi M., Malekzadeh F. Antimicrobial drug resistance and resistance factor transfer among clinical isolates of salmonellae in Iran. Scand J Infect Dis. 1990;22(2):197–203. doi: 10.3109/00365549009037902. [DOI] [PubMed] [Google Scholar]
  12. Gibb A. P., Lewin C. S., Garden O. J. Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess. J Antimicrob Chemother. 1991 Aug;28(2):318–321. doi: 10.1093/jac/28.2.318. [DOI] [PubMed] [Google Scholar]
  13. Gordin F. M., Simon G. L., Wofsy C. B., Mills J. Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med. 1984 Apr;100(4):495–499. doi: 10.7326/0003-4819-100-4-495. [DOI] [PubMed] [Google Scholar]
  14. Heffernan H. M. Antibiotic resistance among Salmonella from human and other sources in New Zealand. Epidemiol Infect. 1991 Feb;106(1):17–23. doi: 10.1017/s0950268800056405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jacoby G. A., Medeiros A. A. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991 Sep;35(9):1697–1704. doi: 10.1128/aac.35.9.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kresken M., Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother. 1988 Aug;32(8):1285–1288. doi: 10.1128/aac.32.8.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ling J. M., Zhou G. M., Woo T. H., French G. L. Antimicrobial susceptibilities and beta-lactamase production of Hong Kong isolates of gastroenteric salmonellae and Salmonella typhi. J Antimicrob Chemother. 1991 Dec;28(6):877–885. doi: 10.1093/jac/28.6.877. [DOI] [PubMed] [Google Scholar]
  18. MacDonald K. L., Cohen M. L., Hargrett-Bean N. T., Wells J. G., Puhr N. D., Collin S. F., Blake P. A. Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA. 1987 Sep 18;258(11):1496–1499. [PubMed] [Google Scholar]
  19. Piddock L. J., Whale K., Wise R. Quinolone resistance in salmonella: clinical experience. Lancet. 1990 Jun 16;335(8703):1459–1459. doi: 10.1016/0140-6736(90)91484-r. [DOI] [PubMed] [Google Scholar]
  20. Piddock L. J., Wray C., McClaren I., Wise R. Quinolone resistance in Salmonella spp: veterinary pointers. Lancet. 1990 Jul 14;336(8707):125–125. doi: 10.1016/0140-6736(90)91648-t. [DOI] [PubMed] [Google Scholar]
  21. Poupart M. C., Chanal C., Sirot D., Labia R., Sirot J. Identification of CTX-2, a novel cefotaximase from a Salmonella mbandaka isolate. Antimicrob Agents Chemother. 1991 Jul;35(7):1498–1500. doi: 10.1128/aac.35.7.1498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Roy C., Foz A., Segura C., Tirado M., Fuster C., Reig R. Plasmid-determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. J Antimicrob Chemother. 1983 Nov;12(5):507–510. doi: 10.1093/jac/12.5.507. [DOI] [PubMed] [Google Scholar]
  23. Ryder R. W., Blake P. A., Murlin A. C., Carter G. P., Pollard R. A., Merson M. H., Allen S. D., Brenner D. J. Increase in antibiotic resistance among isolates of Salmonella in the United States, 1967-1975. J Infect Dis. 1980 Oct;142(4):485–491. doi: 10.1093/infdis/142.4.485. [DOI] [PubMed] [Google Scholar]
  24. Sperber S. J., Schleupner C. J. Salmonellosis during infection with human immunodeficiency virus. Rev Infect Dis. 1987 Sep-Oct;9(5):925–934. doi: 10.1093/clinids/9.5.925. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES